title: Effects of a continuous diltiazem infusion on renal function during cardiac surgery.
abstract: Thirty-five male patients undergoing coronary artery surgery were studied to investigate renal function during a continuous infusion of the calcium channel blocker diltiazem. All patients had preoperative renal function within normal limits (serum creatinine below 0.133 mmol/L) and were randomly divided into three groups: Control (C), Diltiazem 1 (D1), and Diltiazem 2 (D2). Diltiazem was infused in D1 (1 microgram/kg/min) and D2 (2 micrograms/kg/min) patients throughout surgery and during the following 36 hours. Glomerular function was investigated using the endogenous creatinine clearance while tubular function was assessed by means of water and sodium reabsorption tests, as well as urinary enzyme activity measurements. Hemodynamic monitoring was performed using a pulmonary artery catheter. The glomerular filtration rate of C and D1 patients showed a significant fall during cardiopulmonary bypass (CPB) with respect to the prebypass period and returned to the baseline values only in the postoperative period. A similar change was not observed in D2 patients. The analysis of variance demonstrated that the glomerular filtration rate was significantly higher in Group D2 versus Group C during and after CPB (P = 0.03 and P = 0.04, respectively). Furthermore, after CPB, urinary output was significantly improved in D2 patients, both versus C and D1 patients (P = 0.003), notwithstanding a lower mean arterial pressure in the D2 Group (P = 0.04 v C Group). Tubular function was not influenced by diltiazem infusion. It is concluded that a continuous diltiazem infusion, at a dose of 2 micrograms/kg/min during cardiac surgery, may be useful to prevent a decrease in glomerular function secondary to cardiopulmonary bypass.
authors.affiliation: Department of Clinical Nephrology, Battuti General Hospital, Treviso, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Zanardo
authors.forename: P
authors.initials: P
authors.lastname: Michielon
authors.forename: P
authors.initials: P
authors.lastname: Rosi
authors.forename: T
authors.initials: T
authors.lastname: Teodori
authors.forename: F
authors.initials: F
authors.lastname: Antonucci
authors.forename: G
authors.initials: G
authors.lastname: Caenaro
authors.forename: F
authors.initials: F
authors.lastname: Michieletto
authors.forename: G
authors.initials: G
authors.lastname: Simini
mesh_terms: D000118:Acetylglucosaminidase / Q000652:urine; D002315:Cardiopulmonary Bypass; D001026:Coronary Artery Bypass; D003404:Creatinine / Q000097:blood / Q000652:urine; D004110:Diltiazem / Q000008:administration & dosage / Q000627:therapeutic use*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D007430:Intraoperative Care; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D007678:Kidney Glomerulus / Q000187:drug effects; D007684:Kidney Tubules / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D012964:Sodium / Q000652:urine
chemical_list: D012964:Sodium; D003404:Creatinine; D000118:Acetylglucosaminidase; D004110:Diltiazem